BNET produced the numbers by dividing a company’s revenues by its spending on SG&A, producing a revenue yield per $1 of SG&A. Those results were compared to the previous four quarters to identify a trend.
- 20 Drug Companies Ranked by Sales and Marketing Efficiency
- Rank, Name, Yield, Trend
- 01. Gilead: 7.37 Up
- 02. Teva: 4.19 Down
- 03. Genentech: 4.15 Up
- 04. Sanofi: 3.64 Flat
- 05. Abbott: 3.46 Flat
- 06. Pfizer: 3.37 Flat
- 07. Amgen: 3.31 Down
- 08. Wyeth: 3.25 Flat
- 09. Merck: 3.24 Down
- 10. Lilly: 3.20 Flat
- 11. BMS: 3.03 Down
- 12. Novo: 2.94 Up
- 13. AZ: 2.87 Down
- 14. Novartis: 2.74 Down
- 15. Schering: 2.69 Flat
- 16. J&J: 2.68 Down
- 17. GSK: 2.53 Down
- 18. Allergan: 2.44 Down
- 19. Shire: 2.26 Flat
- 20. Sepracor: 2.18 Up
- * Source: Companies’ quarterly earnings statements
Entradas
No hay comentarios:
Publicar un comentario